Key Metrics
CiteScore 

5.2
H-Index 

65
Impact Factor 

< 5
SJR 

Q2Drug Discovery

SNIP 

0.89
Recommended pre-submission checks
Powered by 

Topics Covered on Drug Development Research
Drug Development Research Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
SJR
| Overview | |
| Publisher | WILEY |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 1981 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Drug Development Research ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Drug Development Research
Luliconazole Potentiates Efficacy of Miltefosine Against Leishmania donovani.
- 1 Aug 2026
- Drug development research
Benzimidazole-Based VEGFR-2 Inhibitors Inspired by Sorafenib: Synthesis, Biological Evaluation, and Mechanistic Insights.
- 1 Aug 2026
- Drug development research
Bacterial mRNA Vaccines: Programming Immunity Against Antimicrobial Resistance.
- 1 Aug 2026
- Drug development research
Identification of Sulfonamide-Based Thiazolidine-2,4-Dione Derivatives as VEGFR-2 and Tumor-Associated hCA IX Inhibitors With Hypoxia-Targeted Anti-Colorectal Cancer Activity.
- 1 Aug 2026
- Drug development research
Naphthalene-4H-Chromene Molecular Hybrids as Dual Cholinesterase Inhibitors for the Treatment of Alzheimer's Disease.
- 1 Aug 2026
- Drug development research
Identification of Quinoline Tethered Thiadiazole/Thiazole Derivatives as Potent Tyrosinase Inhibitors With Promising Anti-Toxoplasma gondii Agents: Design, Synthesis, and Computational Analysis.
- 1 Aug 2026
- Drug development research
Luliconazole Potentiates Efficacy of Miltefosine Against Leishmania donovani.
- 1 Aug 2026
- Drug development research
Benzimidazole-Based VEGFR-2 Inhibitors Inspired by Sorafenib: Synthesis, Biological Evaluation, and Mechanistic Insights.
- 1 Aug 2026
- Drug development research
Bacterial mRNA Vaccines: Programming Immunity Against Antimicrobial Resistance.
- 1 Aug 2026
- Drug development research
Identification of Sulfonamide-Based Thiazolidine-2,4-Dione Derivatives as VEGFR-2 and Tumor-Associated hCA IX Inhibitors With Hypoxia-Targeted Anti-Colorectal Cancer Activity.
- 1 Aug 2026
- Drug development research
Naphthalene-4H-Chromene Molecular Hybrids as Dual Cholinesterase Inhibitors for the Treatment of Alzheimer's Disease.
- 1 Aug 2026
- Drug development research
Identification of Quinoline Tethered Thiadiazole/Thiazole Derivatives as Potent Tyrosinase Inhibitors With Promising Anti-Toxoplasma gondii Agents: Design, Synthesis, and Computational Analysis.
- 1 Aug 2026
- Drug development research